Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SMMT |
---|---|---|
09:32 ET | 60483 | 21.63 |
09:34 ET | 19898 | 21.525 |
09:36 ET | 28665 | 21.38 |
09:38 ET | 21777 | 21.3412 |
09:39 ET | 12936 | 21.25 |
09:41 ET | 3691 | 21.31 |
09:43 ET | 12835 | 21.355 |
09:45 ET | 4757 | 21.3069 |
09:48 ET | 12298 | 21.4291 |
09:50 ET | 26836 | 21.34 |
09:52 ET | 16517 | 21.32 |
09:54 ET | 13428 | 21.345 |
09:56 ET | 9963 | 21.41 |
09:57 ET | 5001 | 21.38 |
09:59 ET | 21225 | 21.58 |
10:01 ET | 16194 | 21.5804 |
10:03 ET | 20025 | 21.39 |
10:06 ET | 57267 | 21.33 |
10:08 ET | 15210 | 21.27 |
10:10 ET | 38055 | 20.88 |
10:12 ET | 43145 | 20.6893 |
10:14 ET | 21058 | 20.85 |
10:15 ET | 39944 | 20.85 |
10:17 ET | 18127 | 20.95 |
10:19 ET | 24505 | 20.9 |
10:21 ET | 8873 | 20.93 |
10:24 ET | 27092 | 20.9754 |
10:26 ET | 25200 | 20.97 |
10:28 ET | 36078 | 20.97 |
10:30 ET | 32717 | 20.9267 |
10:32 ET | 12994 | 20.995 |
10:33 ET | 11162 | 21.01 |
10:35 ET | 5107 | 21.075 |
10:37 ET | 9625 | 21.055 |
10:39 ET | 3561 | 21.0604 |
10:42 ET | 13164 | 21.03 |
10:44 ET | 15062 | 21.055 |
10:46 ET | 15609 | 20.99 |
10:48 ET | 21114 | 20.88 |
10:50 ET | 8570 | 20.875 |
10:51 ET | 12851 | 20.77 |
10:53 ET | 21256 | 20.625 |
10:55 ET | 9798 | 20.68 |
10:57 ET | 9915 | 20.64 |
11:00 ET | 12690 | 20.62 |
11:02 ET | 147275 | 20.6099 |
11:04 ET | 59787 | 20.5 |
11:06 ET | 36594 | 20.38 |
11:08 ET | 23725 | 20.3499 |
11:09 ET | 25829 | 20.22 |
11:11 ET | 26852 | 20.12 |
11:13 ET | 26768 | 20.07 |
11:15 ET | 34012 | 20.34 |
11:18 ET | 3628 | 20.3559 |
11:20 ET | 5317 | 20.33 |
11:22 ET | 7729 | 20.495 |
11:24 ET | 12048 | 20.4064 |
11:26 ET | 8811 | 20.3404 |
11:27 ET | 18994 | 20.38 |
11:29 ET | 11063 | 20.37 |
11:31 ET | 9713 | 20.4401 |
11:33 ET | 4526 | 20.48 |
11:36 ET | 7658 | 20.55 |
11:38 ET | 2640 | 20.56 |
11:40 ET | 17950 | 20.53 |
11:42 ET | 16959 | 20.41 |
11:44 ET | 14631 | 20.46 |
11:45 ET | 5181 | 20.495 |
11:47 ET | 6419 | 20.43 |
11:49 ET | 3500 | 20.4259 |
11:51 ET | 13304 | 20.43 |
11:54 ET | 3200 | 20.45 |
11:56 ET | 1800 | 20.43 |
11:58 ET | 3398 | 20.4304 |
12:00 ET | 5802 | 20.48 |
12:02 ET | 3730 | 20.48 |
12:03 ET | 5355 | 20.51 |
12:05 ET | 5350 | 20.5001 |
12:07 ET | 13020 | 20.56 |
12:09 ET | 5235 | 20.5353 |
12:12 ET | 6869 | 20.6 |
12:14 ET | 2106 | 20.64 |
12:16 ET | 15016 | 20.64 |
12:18 ET | 5346 | 20.69 |
12:20 ET | 4955 | 20.6576 |
12:21 ET | 16084 | 20.56 |
12:23 ET | 17934 | 20.65 |
12:25 ET | 2053 | 20.64 |
12:27 ET | 3919 | 20.64 |
12:30 ET | 4281 | 20.61 |
12:32 ET | 6808 | 20.68 |
12:34 ET | 6458 | 20.6 |
12:36 ET | 6324 | 20.69 |
12:38 ET | 3632 | 20.71 |
12:39 ET | 3991 | 20.72 |
12:41 ET | 6731 | 20.645 |
12:43 ET | 3498 | 20.69 |
12:45 ET | 16466 | 20.601 |
12:48 ET | 6217 | 20.6 |
12:50 ET | 5300 | 20.64 |
12:52 ET | 15630 | 20.615 |
12:54 ET | 4632 | 20.6101 |
12:56 ET | 11610 | 20.66 |
12:57 ET | 6044 | 20.63 |
12:59 ET | 7196 | 20.65 |
01:01 ET | 5830 | 20.67 |
01:03 ET | 2402 | 20.69 |
01:06 ET | 6276 | 20.64 |
01:08 ET | 6845 | 20.63 |
01:10 ET | 3500 | 20.62 |
01:12 ET | 10966 | 20.55 |
01:14 ET | 5050 | 20.57 |
01:15 ET | 12521 | 20.61 |
01:17 ET | 1901 | 20.63 |
01:19 ET | 9438 | 20.65 |
01:21 ET | 6300 | 20.63 |
01:24 ET | 4454 | 20.63 |
01:26 ET | 2931 | 20.67 |
01:28 ET | 5963 | 20.63 |
01:30 ET | 1100 | 20.61 |
01:32 ET | 2050 | 20.615 |
01:33 ET | 2391 | 20.73 |
01:35 ET | 6155 | 20.74 |
01:37 ET | 5658 | 20.74 |
01:39 ET | 4586 | 20.71 |
01:42 ET | 2241 | 20.69 |
01:44 ET | 2175 | 20.71 |
01:46 ET | 4243 | 20.74 |
01:48 ET | 8061 | 20.81 |
01:50 ET | 9367 | 20.755 |
01:51 ET | 2665 | 20.775 |
01:53 ET | 3449 | 20.83 |
01:55 ET | 5084 | 20.79 |
01:57 ET | 2820 | 20.84 |
02:00 ET | 7305 | 20.88 |
02:02 ET | 4824 | 20.88 |
02:04 ET | 3855 | 20.85 |
02:06 ET | 7304 | 20.81 |
02:08 ET | 3040 | 20.855 |
02:09 ET | 1729 | 20.87 |
02:11 ET | 2381 | 20.905 |
02:13 ET | 9145 | 20.9599 |
02:15 ET | 13800 | 20.95 |
02:18 ET | 3260 | 20.95 |
02:20 ET | 5736 | 20.93 |
02:22 ET | 4905 | 20.93 |
02:24 ET | 2763 | 20.915 |
02:26 ET | 2063 | 20.92 |
02:27 ET | 9746 | 20.93 |
02:29 ET | 13117 | 20.83 |
02:31 ET | 3947 | 20.835 |
02:33 ET | 2000 | 20.87 |
02:36 ET | 8028 | 20.7493 |
02:38 ET | 9120 | 20.7076 |
02:40 ET | 4441 | 20.69 |
02:42 ET | 2300 | 20.72 |
02:44 ET | 4398 | 20.7 |
02:45 ET | 5534 | 20.688505 |
02:47 ET | 6520 | 20.685 |
02:49 ET | 2139 | 20.66 |
02:51 ET | 4601 | 20.61 |
02:54 ET | 4832 | 20.6 |
02:56 ET | 2984 | 20.61 |
02:58 ET | 5660 | 20.71 |
03:00 ET | 12621 | 20.7003 |
03:02 ET | 7602 | 20.731 |
03:03 ET | 3666 | 20.75 |
03:05 ET | 3835 | 20.7428 |
03:07 ET | 1600 | 20.751 |
03:09 ET | 8536 | 20.79 |
03:12 ET | 3796 | 20.79 |
03:14 ET | 7226 | 20.77 |
03:16 ET | 4705 | 20.8 |
03:18 ET | 4383 | 20.76 |
03:20 ET | 3022 | 20.8 |
03:21 ET | 18543 | 20.84 |
03:23 ET | 5010 | 20.841 |
03:25 ET | 9930 | 20.88 |
03:27 ET | 8924 | 20.88 |
03:30 ET | 4527 | 20.89 |
03:32 ET | 8059 | 20.781 |
03:34 ET | 2930 | 20.76 |
03:36 ET | 7591 | 20.75 |
03:38 ET | 6906 | 20.68 |
03:39 ET | 8821 | 20.705 |
03:41 ET | 8453 | 20.76 |
03:43 ET | 4760 | 20.76 |
03:45 ET | 10013 | 20.67 |
03:48 ET | 17379 | 20.565 |
03:50 ET | 12015 | 20.63 |
03:52 ET | 63791 | 20.12 |
03:54 ET | 178080 | 20.02 |
03:56 ET | 115897 | 19.875 |
03:57 ET | 56315 | 19.94 |
03:59 ET | 579592 | 20.1 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Summit Therapeutics Inc | 14.8B | -87.4x | --- |
Vaxcyte Inc | 15.4B | -25.0x | --- |
Insmed Inc | 12.5B | -13.5x | --- |
Ascendis Pharma A/S | 8.9B | -15.4x | --- |
Revolution Medicines Inc | 7.5B | -12.4x | --- |
Viking Therapeutics Inc | 6.9B | -66.1x | --- |
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.8B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 735.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.93 |
EPS | $-0.23 |
Book Value | $0.11 |
P/E Ratio | -87.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.